Wells Fargo & Company Finch Therapeutics Group, Inc. Put Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
About Finch Therapeutics Group, Inc.
- Ticker FNCH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,688,400
- Market Cap $575M
- Description
- Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...